NUS
Next earnings: Aug 6, 2026 · After close
Signal
Mixed11
Price
1
Move-2.55%Negative session
Volume
1
Volume1.3× avgNormal activity
Technical
1
RSIRSI 26Oversold — bounce setup
PRICE
Prev Close
6.28
Open
6.24
Day Range6.12 – 6.32
6.12
6.32
52W Range6.11 – 14.62
6.11
14.62
0% of range
VOLUME & SIZE
Avg Volume
537.1K
FUNDAMENTALS
P/E Ratio
5.7x
Value territory
EPS (TTM)
Div Yield
0.04%
Beta
0.95
Market-like
Performance
1D
-2.55%
5D
-7.83%
1M
-21.44%
3M
-26.79%
6M
-36.38%
YTD
-36.38%
1Y
-18.07%
Worst: 6M (-36.38%)
Quick Read
TrendInsufficient MA data
Momentum
NEUTRAL
rev -14% · 69% gross margin
Valuation
CHEAP
P/E 6x vs ~20x sector
Health
STRONG
CR 2.0 · FCF $0.86/sh
Bullish
Key MetricsTTM
Market Cap$297.13M
Revenue TTM$1.44B
Net Income TTM$54.52M
Free Cash Flow$41.57M
Gross Margin69.3%
Net Margin3.8%
Operating Margin5.7%
Return on Equity6.8%
Return on Assets4.0%
Debt / Equity0.35
Current Ratio2.03
EPS TTM$1.13
Alpha SignalsFull Analysis →
What Moves This Stock

Mainland China revenue trends and regulatory environment - historically 30-40% of total revenue, subject to direct-selling license restrictions and government crackdowns on MLM practices

Active distributor count and productivity metrics - total distributor base size, sales leaders (high-volume distributors), average revenue per distributor

New product launch success rates - particularly ageLOC beauty device adoption and Pharmanex supplement line extensions that drive distributor excitement and recruitment

Currency fluctuations in key markets - significant exposure to Chinese yuan, Korean won, Japanese yen with limited hedging programs

Macro Sensitivity
Economic Cycle

moderate-to-high - Premium discretionary personal care and supplements are economically sensitive purchases. Distributor recruitment slows during recessions as side-income opportunities become less attractive. However, MLM models can paradoxically see recruitment spikes during early recession phases as unemployed workers seek income alternatives. Consumer spending weakness in China (50%+ of revenue exposure) directly impacts results. The -14.3% revenue decline suggests cyclical vulnerability.

Interest Rates

Low direct sensitivity as the company carries modest debt (0.45x D/E) and generates positive free cash flow. However, rising rates indirectly pressure valuation multiples for cash-generative businesses and may reduce distributor willingness to invest in inventory purchases if consumer credit tightens. Distributor financing for starter kits and inventory can be affected by consumer credit availability.

Key Risks

Secular decline in MLM business model legitimacy - regulatory scrutiny intensifying globally, particularly in China where government has periodically restricted direct-selling licenses. Younger consumers increasingly view MLM as pyramid schemes, limiting recruitment pipeline

E-commerce and social media disruption - Traditional MLM face-to-face selling model losing relevance as consumers shift to Amazon, Sephora, and direct-brand websites. Digital-native brands (The Ordinary, Glossier) capture anti-aging market share at lower price points

China regulatory risk - Direct-selling licenses subject to arbitrary government restrictions, with precedent of multi-month business suspensions. Geopolitical tensions could trigger targeted enforcement against US-based MLM companies

Investor Profile

value/special situations - The 0.3x P/S and 0.5x P/B ratios attract deep-value investors betting on business stabilization or activist intervention. 11.1% FCF yield appeals to income-focused value investors. High ROE (20.4%) despite distressed valuation suggests potential for mean reversion if operational challenges resolve. Not suitable for growth or ESG investors given structural MLM model concerns and negative revenue growth. Recent 210% EPS growth from depressed base may attract momentum traders, but underlying revenue decline limits sustainability.

Watch on Earnings
Mainland China revenue trends (constant currency) and active distributor count in the regionUSD/CNY exchange rate movements given significant yuan-denominated revenue exposureUS and China consumer sentiment indices as leading indicators for discretionary premium product demandActive sales leader count (top-tier distributors) as predictor of network health and recruitment momentum
Health Radar
3 strong1 watch2 concern
52/100
Liquidity
2.03Strong
Leverage
0.35Strong
Coverage
5.5xStrong
ROE
6.8%Concern
ROIC
6.1%Concern
Cash
$239MWatch
ANALYST COVERAGE11 analysts
HOLD
+79.7%upside to target
Hold
1091%
Sell
19%
0 Buy (0%)10 Hold (91%)1 Sell (9%)
Full report →
Stock Health
Composite Score
1 of 5 signals bullish
3/10
Technicals
RSI RangeRSI 26 — Oversold, watch for bounce
~
Volume
Volume FlowDistribution — institutional selling
Fundamentals
Last EarningsMissed estimates
Analyst ConsensusHold
~
LiquidityCurrent Ratio 2.03 — healthy liquidity
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentSep 18, 2026
In 125 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

DowntrendDeath Cross · 50D trails 200D by 24.4%

-16.6% vs SMA 50 · -36.9% vs SMA 200

Momentum

RSI26.0
Oversold — potential bounce
MACD-0.32
Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$14.62+138.9%
EMA 200
$8.92+45.8%
EMA 50
$7.52+22.9%
Current
$6.12
52W Low
$6.11-0.2%
52-Week RangeNear 52-week low
$6.110th %ile$14.62
Squeeze SetupVolume-based
Distribution Pressure

Heavy distribution on elevated volume — institutions appear to be exiting. Squeeze setups unlikely while selling pressure persists.

20-Day Money Flow
Acc days:2
Dist days:6
Edge:+4 dist
Volume Context
Avg Vol (50D)510K
Recent Vol (5D)
775K+52%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 2 analysts
Analyst revisions:Revenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2023
$1.8B
$1.8B$1.8B
-$2.99
Low1
FY2024
$1.7B
$1.7B$1.7B
-6.6%$0.68
±2%
Low2
FY2025
$1.5B
$1.5B$1.5B
-13.1%$1.30+92.6%
Low1
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryNUS
Last 8Q
+23.6%avg beat
Beat 5 of 8 quartersMissed 3 Estimates rising
+17%
Q3'24
-15%
Q4'24
+58%
Q1'25
+53%
Q2'25
+72%
Q3'25
+13%
Q4'25
-3%
Q1'26
-7%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Insider Activity
SEC Filings →
1 Buy/5 SellsNet Selling
NET SELLERS$0 bought · $18K sold · 30d window
Nathanson LauraDir
$18K
May 11
SELL
Hatchett Steven Kei…Chief Product …
$53K
Nov 11
BUY
Nathanson LauraDir
$79K
Sep 4
SELL
Clark Chayce DavidEVP and Genera…
$239K
Sep 3
SELL
Campbell Daniel WDir
$283K
Aug 29
SELL
Campbell Daniel WDir
$110K
Aug 29
SELL
Financials
Dividends3.92% yield
3 yrs of payments
Annual Yield3.92%
Quarterly Div.$0.0600
Est. Annual / Share$0.24
FrequencyQuarterly
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26
Q2'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

1
BlackRock, Inc.
4.3M
2
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
2.1M
3
AMERICAN CENTURY COMPANIES INC
2.0M
4
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
1.8M
5
ACADIAN ASSET MANAGEMENT LLC
1.8M
6
DIMENSIONAL FUND ADVISORS LP
1.7M
7
RENAISSANCE TECHNOLOGIES LLC
1.7M
8
AQR CAPITAL MANAGEMENT LLC
1.2M
News & Activity

NUS News

About

founded 35 years ago, nu skin enterprises, inc. (nse) empowers innovative companies to change the world with sustainable solutions, opportunities, technologies, and life-improving values. the company currently focuses its efforts around innovative consumer products, product manufacturing and automated controlled environment agriculture technology. the nse family of companies includes: nu skin, groviv, wasatch labs, elevate health sciences, and casepak. nu skin enterprises is traded on the new york stock exchange under the symbol "nus." more information is available at nuskinenterprises.com.

Industry
Toilet Preparation Manufacturing
CEO
Ritch Wood
Chayce David ClarkExecutive VP, COO & Chief Legal Officer
Pakapun LeevutinunPresident of Southeast Asia & Pacific
James D. ThomasExecutive Vice President & Chief Financial Officer
PeersConsumer Defensive(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
NUS
$6.12-2.55%$297M5.4-1425.6%1078.7%1500
$131.45-0.76%$1.0T47.9+472.5%307.0%1520
$1048.95+0.74%$465.4B54.5+816.7%294.3%1507
$80.82+0.46%$347.7B25.4+187.0%2734.0%1508
$141.57-0.80%$329.7B20.5+29.2%1895.3%1486
$189.61-1.17%$295.5B26.7+731.3%2791.8%1509
$149.12+0.30%$203.8B23.3+225.5%877.3%1488
Sector avg-0.54%29.1+148.1%1425.5%1503